XYRA Doses First European Patient in Budiodarone Trial
BASEL, Switzerland, Aug. 31, 2026 XYRA LLC announced that the first patient in Europe has been dosed in the...
Hemagglutinin
Advertisement
Kyowa Kirin Reaches U.S. Agreement to Lower Medicine Costs
TOKYO, Japan and PRINCETON, New Jersey, Aug. 31/Sept. 1, 2026 Kyowa Kirin Co., Ltd. announced a voluntary agreement with...
GSK Advances mRNA Flu Vaccine to Phase III After Data
LONDON, UK, Sept. 1, 2026 GSK announced that it will advance its investigational mRNA seasonal influenza vaccine candidate into...
Celcuity Files FDA sNDA for REVTORPYK in Breast Cancer
Minneapolis, Minnesota, United States, Aug. 26, 2026 Celcuity Inc., a biotechnology company developing targeted therapies for solid tumors, has...
Osivax, GC Biopharma Partner on Next-Gen Flu Vaccine
Lyon, France and Yongin, Republic of Korea, Aug. 26, 2026 Osivax, a clinical-stage biopharmaceutical company developing broad-spectrum influenza vaccines,...
Advertisement
